Literature DB >> 14685882

The value of screening for multiple arterio-venous malformations in hereditary hemorrhagic telangiectasia: a diagnostic study.

Benedikt J Folz1, Ana Cerra Wollstein, Heiko Alfke, Anja A Dünne, Burkard M Lippert, Konrad Görg, Hans-Joachim Wagner, Siegfried Bien, Jochen A Werner.   

Abstract

Occult visceral arterio-venous malformations (AVMs) may be a constant threat to patients suffering from hereditary hemorrhagic telangiectasia (HHT), also known as Rendu-Osler-Weber syndrome (M. ROW). HHT patients predominantly become symptomatic through chronic, recurrent epistaxis, a symptom that can alert physicians at an early stage of the disease. The purpose of this study was to investigate whether occult, visceral arterio-venous malformations could be detected by screening imaging studies in patients suffering from HHT. In a comprehensive diagnostic study, Rendu-Osler-Weber patients were examined for potential visceral arterio-venous malformations by physical examination and non-invasive imaging techniques. The Department of Otolaryngology of the Philipps University of Marburg is a major referral center and coordinated the screening procedures. Thirty-five individuals with the presumed diagnosis of HHT gave informed consent to the screening investigations. Eighteen of 35 individuals were found to suffer from visceral vascular malformations; most of the AVMs were diagnosed in the lung, but also the liver, spleen, brain and eyes were affected. Six patients could be treated preventively by arterial embolization for AVMs of the lung, liver and brain. Comprehensive screening for occult AVMs in HHT patients seems to be justified to avert potential complications in this group of patients.

Entities:  

Mesh:

Year:  2003        PMID: 14685882     DOI: 10.1007/s00405-003-0719-3

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  43 in total

1.  Fatal outcome after embolotherapy for hepatic arteriovenous malformations of the liver in two patients with hereditary hemorrhagic telangiectasia.

Authors:  J H Whiting; J R Korzenik; F J Miller; J S Pollack; R I White
Journal:  J Vasc Interv Radiol       Date:  2000 Jul-Aug       Impact factor: 3.464

2.  Angiographic and clinical characteristics of patients with cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia.

Authors:  S Matsubara; J L Mandzia; K ter Brugge; R A Willinsky; M E Faughnan; J L Manzia
Journal:  AJNR Am J Neuroradiol       Date:  2000 Jun-Jul       Impact factor: 3.825

3.  Hereditary hemorrhagic telangiectasia; review of 102 cases and presentation of an innovation to septodermoplasty.

Authors:  R H Stecker; C F Lake
Journal:  Arch Otolaryngol       Date:  1965-11

Review 4.  [Hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease) and its manifestation in the liver].

Authors:  M Caselitz; A Chavan; M P Manns; S Wagner
Journal:  Z Gastroenterol       Date:  2001-07       Impact factor: 2.000

5.  Pial arteriovenous fistula in children as presenting manifestation of Rendu-Osler-Weber disease.

Authors:  R García-Mónaco; W Taylor; G Rodesch; H Alvarez; P Burrows; P Coubes; P Lasjaunias
Journal:  Neuroradiology       Date:  1995-01       Impact factor: 2.804

6.  The natural history of epistaxis in hereditary hemorrhagic telangiectasia.

Authors:  O S AAssar; C M Friedman; R I White
Journal:  Laryngoscope       Date:  1991-09       Impact factor: 3.325

7.  Hereditary haemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2.

Authors:  M Piantanida; E Buscarini; C Dellavecchia; A Minelli; A Rossi; L Buscarini; C Danesino
Journal:  J Med Genet       Date:  1996-06       Impact factor: 6.318

8.  Life-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia.

Authors:  B A Ference; T M Shannon; R I White; M Zawin; C M Burdge
Journal:  Chest       Date:  1994-11       Impact factor: 9.410

9.  A third locus for hereditary haemorrhagic telangiectasia maps to chromosome 12q.

Authors:  P Vincent; H Plauchu; J Hazan; S Fauré; J Weissenbach; J Godet
Journal:  Hum Mol Genet       Date:  1995-05       Impact factor: 6.150

10.  Hereditary hemorrhagic telangiectasia with growing pulmonary arteriovenous fistulas followed for 24 years.

Authors:  M Teragaki; K Akioka; M Yasuda; Y Ikuno; H Oku; K Takeuchi; T Takeda
Journal:  Am J Med Sci       Date:  1988-06       Impact factor: 2.378

View more
  4 in total

Review 1.  Neurocutaneous Disorders for the Practicing Neurologist: a Focused Review.

Authors:  Anna Carolina Paiva Costa T Figueiredo; Nikolas Mata-Machado; Matthew McCoyd; José Biller
Journal:  Curr Neurol Neurosci Rep       Date:  2016-02       Impact factor: 5.081

2.  First experiences with an individual nasal olive in patients with hereditary haemorrhagic telangiectasia (HHT).

Authors:  Basel Al Kadah; George Papaspyrou; Mathias Schneider; Bernhard Schick
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-05-23       Impact factor: 2.503

3.  Manifestations of hereditary hemorrhagic telangiectasia in children and adolescents.

Authors:  Benedikt J Folz; Barbara Zoll; Heiko Alfke; André Toussaint; Rolf F Maier; Jochen A Werner
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-06-24       Impact factor: 2.503

4.  Splenic Involvement in Hereditary Hemorrhagic Telangiectasia.

Authors:  Susumu Takamatsu; Kota Sato; Shunsuke Kato; Hiroto Nagano; Shunro Ohtsukasa; Yasuyuki Kawachi
Journal:  Case Rep Med       Date:  2016-10-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.